Cargando…
Advances in Subcutaneous Delivery Systems of Biomacromolecular Agents for Diabetes Treatment
Diabetes mellitus is a major threat to human health. Both its incidence and prevalence have been rising steadily over the past few decades. Biomacromolecular agents such as insulin and glucagon-like peptide 1 receptor agonists are commonly used hypoglycemic drugs that play important roles in the tre...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7898203/ https://www.ncbi.nlm.nih.gov/pubmed/33628020 http://dx.doi.org/10.2147/IJN.S283416 |